Centiva Capital LP Trims Position in MultiPlan Co. (NYSE:MPLN)

Centiva Capital LP trimmed its position in MultiPlan Co. (NYSE:MPLNFree Report) by 98.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,176 shares of the company’s stock after selling 823,824 shares during the quarter. Centiva Capital LP’s holdings in MultiPlan were worth $101,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of MPLN. Point72 DIFC Ltd bought a new position in MultiPlan in the 2nd quarter valued at $43,000. Cubist Systematic Strategies LLC bought a new stake in MultiPlan during the second quarter valued at $72,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in MultiPlan during the second quarter valued at $245,000. Millennium Management LLC grew its position in MultiPlan by 3,401.0% during the second quarter. Millennium Management LLC now owns 8,426,081 shares of the company’s stock worth $3,273,000 after buying an additional 8,185,402 shares in the last quarter. Finally, AQR Capital Management LLC increased its stake in MultiPlan by 386.2% in the 2nd quarter. AQR Capital Management LLC now owns 2,742,735 shares of the company’s stock worth $1,065,000 after acquiring an additional 2,178,590 shares during the last quarter. 87.15% of the stock is currently owned by institutional investors.

MultiPlan Stock Performance

NYSE MPLN opened at $7.20 on Friday. The stock’s fifty day moving average is $8.53. MultiPlan Co. has a 52-week low of $4.80 and a 52-week high of $69.20. The company has a debt-to-equity ratio of 21.73, a current ratio of 1.05 and a quick ratio of 1.05. The company has a market cap of $116.43 million, a P/E ratio of -0.08 and a beta of 0.42.

Wall Street Analysts Forecast Growth

Separately, Citigroup dropped their price target on MultiPlan from $17.20 to $10.00 and set a “neutral” rating for the company in a research report on Monday, September 23rd.

Read Our Latest Stock Analysis on MPLN

MultiPlan Profile

(Free Report)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.

Featured Articles

Want to see what other hedge funds are holding MPLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MultiPlan Co. (NYSE:MPLNFree Report).

Institutional Ownership by Quarter for MultiPlan (NYSE:MPLN)

Receive News & Ratings for MultiPlan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MultiPlan and related companies with MarketBeat.com's FREE daily email newsletter.